Serotonin and norepinephrine neurotransmitters are intimately involved in a number of neurochemical and physiological processes, such as depression and pain disorders. Selective serotonin or norepinephrine reuptake inhibitors are the important class of antidepressants, such as fluoxetine, nisoxetine, tomoxetine, and duloxetine featuring the structural similarity of 1-ary-3-aminopropanol.
8
In continuation of our earlier efforts towards the preparation of biologically important compounds particularly possessing a chiral aminoalcohol unit, 9 siproborate estercatalyzed ketone reduction caught our attention. Recently, the chiral spiroborate esters derived from amino alcohols showed high catalytic activity toward reductions of simple aromatic ketones and oxime ethers.
10 The reaction bypassed the need for highly air/moisture-sensitive and precious metal catalysts or expensive reducing agents. We envisaged, thus, that a strategy to improve application development is particularly valuable in scale-up synthesis of active pharmaceutical ingredients. Herein we report an asymmetric borane reduction of 3-chloro-1-(2-thienyl)-1-propanone mediated by tetra-coordinated spiroborate ester to highlight the enantioselective synthesis of the antidepressant drug (S)-duloxetine (1) .
The β-chloro ketone 2 was available through Friedel-Crafts acylation of thiophene with 3-chloropropionyl chloride in the presence of aluminum chloride as the Lewis acid catalyst.
11
Spiroborate esters 3a-3e were readily prepared by heating equimolar amount of chiral 1,1-diaryl-2-aminoethanols derived from amino acids, 1,2-diols, and triisopropyl borate in toluene, according to the literature procedures.
12 They are white, crystalline solids and stable for long term storage.
We first examined an asymmetric reduction of 2 with borane dimethyl sulfide (0.7 equiv) in the presence of (S)-3a (10 mol %) in THF at room temperature. Indeed, the reduction was completed within 1 h to give (R)-4 in 91% yield with 77% ee (entry 1). Enantiomeric excess (ee) was determined by GC using a chiral column (CP-Chirasil-Dex CB). The effectiveness of several spiroborate ester catalysts was investigated under the same conditions and the results are summarized in Table 1 . Among them, diphenylprolinol-derived (S)-3b revealed good yield with high enantioselectivity (entry 2). Furthermore, even the catalyst loading was reduced to 5 mol %, a complete conversion was sustained with no loss of enantioselectivity (entry 3). However, there is a significant deterioration in enantioselectivity upon changes associated with the 1,2-diol partners from ethylene glycol to highly hindered diols such as pinacol or catechol, presumably, due to the steric congestion to the incoming ketone substrate (entries 6 and 7).
Synthesis of (S)-duloxetine is quite straightforward and the results are illustrated in Scheme 1. Again, asymmetric Notes Bull. Korean Chem. Soc. 2014 , Vol. 35, No. 6 1895 borane reduction of 2 using (R)-3b in THF gave the chloroalcohol (S)-4 in 92% yield with 95% ee. Treatment of (S)-4 with saturated sodium iodide in acetone at reflux for 12 h provided iodo-alcohol, which was used for the next reaction without any purification. Thus, reaction of the iodide with 40% aqueous methylamine at room temperature for 6 h provided amino-alcohol (S)-5 in 71% yield. The final installation was then carried out by nucleophilic aromatic substitution of (S)-5 with 1-fluoronaphthalene employing sodium hydride in DMSO to afford (S)-duloxetine (1) in 78% yield with 96% ee.
In summary, we have prepared (S)-duloxetine from 3-chloro-1-(2-thienyl)-1-propanone in good yield with an excellent enantioselectivity via asymmetric borane reduction catalyzed by the spiroborate ester. The mild reaction conditions and operational simplicity make this method attractive for a practical synthesis of (S)-duloxetine, a potent dual inhibitor of serotonin and norepinephrine reuptake.
Experimental
Preparation of 3-Chloro-1-(2-thienyl)-1-propanone (2) . The β-chloro ketone 2 was prepared through Friedel-Crafts acylation of thiophene with 3-chloropropionyl chloride in the presence of AlCl 3 .
11 Yield: 19.2 g (95%); 1 H NMR (300 MHz, CDCl 3 ) δ 7.74 (dd, 1H, J = 3.8, 1.1 Hz), 7.67 (dd, 1H, J = 4.9, 1.1 Hz), 7.14 (dd, 1H, J = 5.0, 3.8 Hz), 3.90 (t, 2H, J = 6.8 Hz), 3.40 (t, 2H, J = 6.8 Hz); MS (EI) m/z (%) 174 (M + , 58), 139 (50), 111 (100), 83 (30). Preparation of (R)-2-[(1,3,2-Dioxaborolan-2-yloxy)diphenylmethyl]pyrrolidine, (R)-3b. The (R)-3b was prepared as a white crystalline precipitate by heating equimolar amount of (R)-α,α-diphenyl-2-pyrrolidinemethanol, ethylene glycol, and triisopropyl borate in toluene. Synthesis of (S)-3-Chloro-1-(2-thienyl)-1-propanol, (S)-4. To a stirred solution of (R)-3b (215 mg, 0.66 mmol) in anhydrous THF (20 mL), BH 3 ·SMe 2 (634 mg, 8.34 mmol) was added in one portion under nitrogen atmosphere. The resulting mixture was stirred for 15 min until a transparent solution was observed. To this solution, a solution of 1 (2.09 g, 11.9 mmol) in THF (5 mL) was added dropwise for 5 min. The resulting mixture was stirred at room temperature for 1 h, and quenched with MeOH (5 mL). The solvents were removed under reduced pressure and the residue was partitioned with EtOAc and water. The aqueous phase was extracted with EtOAc (3 × 10 mL). The combined organic phases were washed with brine, dried over Na 2 SO 4 , and then evaporated under reduced pressure. The crude was purified by silica gel column chromatography on silica gel (hexane/ EtOAc = 3/1) to afford (S)-4 (1.93 g, 92%) as an oil. = −5.60 (c 1.2, MeOH); Synthesis of (S)-3-Iodo-1-(2-thienyl)-1-propanol. A mixture of (S)-4 (390 mg, 2.20 mmol) and a NaI-saturated acetone solution (20 mL) was stirred at reflux overnight in a dark place away from light. The mixture was filtered to remove the precipitated NaCl and the filtrate was concentrated in vacuo. The residue was dissolved in water (20 mL) and extracted with Et 2 O (3 × 10 mL). The combined organic extracts were washed with brine, dried over Na 2 SO 4 , and concentrated to yield the corresponding iodide (560 mg) as a Notes yellow oil. This material was used without any further purification. Synthesis of (S)-3-Methylamino-1-(2-thienyl)-1-propanol, (S)-5. To a solution of the previously prepared iodide (560 mg, 2.08 mmol) in THF (5 mL), was added 40% aqueous MeNH 2 (2.2 mL, 25.4 mmol). The resulting mixture was stirred at room temperature for 6 h. The reaction mixture was treated with 5 N NaOH (1 mL), and then concentrated in vacuo. The residue was dissolved in water (20 mL) and extracted with Et 2 O (3 × 20 mL). The combined extracts were washed with brine, dried over Na 2 SO 4 , and concentrated in vacuo. 7, 126.5, 123.7, 122.3, 72.1, 50.2, 36.8, 35.9 ; MS (EI) m/z (%) 171 (M + , 35), 139 (22), 128 (100), 111(31). Synthesis of (S)-Duloxetine (1) . To a solution of (S)-5 (171 mg, 1 mmol) in DMSO (5 mL), were added NaH (36 mg 1.5 mmol) and 1-fluoronaphthalene (190 mg, 1.3 mmol) . After stirring for 8 h, the reaction mixture was partitioned with ethyl acetate and water. After an extractive workup, the combined organic layers were dried over sodium sulfate and then concentrated in vacuo. 3, 145.2, 134.5, 127.4, 126.5, 126.2, 126.1, 125.7, 125.2, 124.6, 124.5, 122.1, 120.5, 106.9, 74.7, 48.3, 39.0, 36.5 ; MS (EI) m/z (%) 297 (M + , 4), 187 (80), 153 (69), 144 (100); HPLC analysis: (Chiralcel OD-H, hexane/IPA = 85/15, 0.5 mL/min; t 1 = 18 min (S), t 2 = 25 min (R); ee = 96%.
